Research ArticleRESEARCH

Effect of Terminal Sterilization by Irradiation on Amber Type I and Type III Glass Containers Containing Veterinary Oxytetracycline Suspension

Joseph Wong, Pavlos Papadopoulos, Christine Rebbeck, Susan Schwabe, Gary Lischewski, James Melchert, Wei Kuu, Thomas Agostinelli, Thomas Smith, Glenn Brame, Randy Lynn and Douglas Hepler
PDA Journal of Pharmaceutical Science and Technology January 2004, 58 (1) 6-14;

Article Information

vol. 58 no. 1 6-14
PubMed 
15053050
Published By 
Parenteral Drug Association (PDA)
Print ISSN 
1079-7440
Online ISSN 
1948-2124
History 
  • Published online January 1, 2004.
Copyright & Usage 
Copyright © Parenteral Drug Association. All rights reserved.

Author Information

  1. Joseph Wong1,*,
  2. Pavlos Papadopoulos1,
  3. Christine Rebbeck1,
  4. Susan Schwabe1,
  5. Gary Lischewski1,
  6. James Melchert1,
  7. Wei Kuu1,
  8. Thomas Agostinelli2,
  9. Thomas Smith2,
  10. Glenn Brame2,
  11. Randy Lynn3 and
  12. Douglas Hepler3
  1. 1Pharmaceutical Research and Development/ Scientific Affairs, Baxter Healthcare Corporation, Round Lake, IL
  2. 2Manufacturing Plant, Baxter Healthcare Corporation, Cleveland, MS, and
  3. 3IDEXX Pharmaceuticals, Inc., Greensboro, NC
  1. *Author to whom correspondence should be addressed:
    Pharmaceutical R&D, Baxter Healthcare Corporation, Baxter Technology Park, Route 120 and Wilson Road, Round Lake, Illinois 60073.
    Phone: 847-270-5972. E-mail: joe_wong{at}baxter.com

Cited By...

Back to top

In This Issue

Download PDF
Article Alerts
Email Article
Citation Tools
Effect of Terminal Sterilization by Irradiation on Amber Type I and Type III Glass Containers Containing Veterinary Oxytetracycline Suspension
Joseph Wong, Pavlos Papadopoulos, Christine Rebbeck, Susan Schwabe, Gary Lischewski, James Melchert, Wei Kuu, Thomas Agostinelli, Thomas Smith, Glenn Brame, Randy Lynn, Douglas Hepler
PDA Journal of Pharmaceutical Science and Technology Jan 2004, 58 (1) 6-14;
Twitter logo Facebook logo Mendeley logo

Jump to section